Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Go back to Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update| (NASDAQ: XENE) | Delayed: 59.94 -1.02 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.96 | 52 Week High | $9.75 | |||
| Open | $60.78 | 52 Week Low | $5.65 | |||
| Day High | $61.17 | P/E | N/A | |||
| Day Low | $59.82 | EPS | $0.00 | |||
| Volume | 273,198 | |||||

